INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE (INSERM) has a total of 12 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are DONG A SOCIO HOLDINGS CO LTD, CEN JUNDA and UNIV LEUVEN KATH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Bertrand Olivier | 1 |
#2 | Smolarek Dorota | 1 |
#3 | Lambert Gregory | 1 |
#4 | Bru-Mercier Gilles | 1 |
#5 | Chettab Abdelkamel | 1 |
#6 | Guichou Jean-François | 1 |
#7 | Daudon Michel | 1 |
#8 | Van Beers Bernard | 1 |
#9 | Miyagi Atsushi | 1 |
#10 | Pawlotsky Jean-Michel | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017191015A1 | A method of operating an afm | |
EP3268027A1 | Hepcidin antagonists for use in the treatment of inflammation | |
US2016083481A1 | Fusion proteins and immunoconjugates and uses thereof which are specific for glycophorin A |